nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients
|
Adam, E.H. |
|
|
194 |
C |
p. 42-44 |
artikel |
2 |
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
|
Nichetti, Federico |
|
|
194 |
C |
p. 176-177 |
artikel |
3 |
Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
|
Pavoni, Vittorio |
|
|
194 |
C |
p. 190-191 |
artikel |
4 |
Clinical management and follow-up of relapsed immune thrombotic thrombocytopenic purpura during pregnancy: A case report
|
Marcellini Antonio, Shally |
|
|
194 |
C |
p. 91-94 |
artikel |
5 |
Combined prognostic significance of D-dimer level and platelet count in acute ischemic stroke
|
Liu, Yue |
|
|
194 |
C |
p. 142-149 |
artikel |
6 |
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg
|
Pizzolo, Francesca |
|
|
194 |
C |
p. 216-219 |
artikel |
7 |
Determination of the reference range of platelet aggregation using a new automatic coagulation analyzer and visualization of platelet function data
|
Yoshida, Makiko |
|
|
194 |
C |
p. 95-97 |
artikel |
8 |
Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials
|
Haykal, Tarek |
|
|
194 |
C |
p. 57-65 |
artikel |
9 |
Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome
|
Yun, Jae Won |
|
|
194 |
C |
p. 45-53 |
artikel |
10 |
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review
|
Li, Allen |
|
|
194 |
C |
p. 240-245 |
artikel |
11 |
Editorial Board
|
|
|
|
194 |
C |
p. IFC |
artikel |
12 |
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy
|
Di Minno, Alessandro |
|
|
194 |
C |
p. 229-236 |
artikel |
13 |
Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry
|
del-Toro-Cervera, Jorge |
|
|
194 |
C |
p. 178-182 |
artikel |
14 |
Fibrinogen Clauss and prothrombin time derived method ratio can differentiate dysfibrinogenemia from hypofibrinogenemia and hyperfibrinogenemia
|
Luo, Meiling |
|
|
194 |
C |
p. 197-199 |
artikel |
15 |
Flow cytometric analysis of platelet function to improve the recognition of thrombocytopathy
|
Huskens, Dana |
|
|
194 |
C |
p. 183-189 |
artikel |
16 |
How to optimize the value of administrative venous thromboembolism codes
|
Albertsen, Ida Ehlers |
|
|
194 |
C |
p. 195-196 |
artikel |
17 |
Impact of direct oral anticoagulant therapy on operative delay, blood loss, transfusion and postoperative morbidity mortality in hip fracture patient, an observational study
|
Gautier, Nicolas |
|
|
194 |
C |
p. 165-167 |
artikel |
18 |
Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study
|
Stessel, Björn |
|
|
194 |
C |
p. 209-215 |
artikel |
19 |
Incidence and risk factors of subclinical umbilical catheter-related thrombosis in neonates
|
Hwang, Ji Hye |
|
|
194 |
C |
p. 21-25 |
artikel |
20 |
Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal
|
Makhoul, Therese |
|
|
194 |
C |
p. 158-164 |
artikel |
21 |
Increased rates of hand ischemia following arterial cannulation in patients with severe COVID19-related pneumonia
|
Dorigo, Walter |
|
|
194 |
C |
p. 33-35 |
artikel |
22 |
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review
|
Fletcher-Sandersjöö, Alexander |
|
|
194 |
C |
p. 36-41 |
artikel |
23 |
Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive?
|
Kovacs, Matthew R. |
|
|
194 |
C |
p. 119-120 |
artikel |
24 |
Mucin mutations and aberrant expression are associated with the pathogenesis of immune thrombocytopenia
|
Zhu, Jing-jing |
|
|
194 |
C |
p. 222-228 |
artikel |
25 |
Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review
|
Plana, Emma |
|
|
194 |
C |
p. 200-208 |
artikel |
26 |
Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation
|
Zhang, Gao-Chao |
|
|
194 |
C |
p. 168-175 |
artikel |
27 |
Patient outcomes in myeloproliferative neoplasm-related thrombosis: Insights from the National Inpatient Sample
|
Ulanja, Mark B. |
|
|
194 |
C |
p. 72-81 |
artikel |
28 |
Patients experience of living with cancer associated thrombosis in France (Le PELICAN)
|
Mahé, Isabelle |
|
|
194 |
C |
p. 66-71 |
artikel |
29 |
Performance of 18F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis
|
Robin, Philippe |
|
|
194 |
C |
p. 153-157 |
artikel |
30 |
Portal vein thrombosis in a patient with COVID-19
|
Franco-Moreno, A. |
|
|
194 |
C |
p. 150-152 |
artikel |
31 |
Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteers
|
Lisman, Ton |
|
|
194 |
C |
p. 237-239 |
artikel |
32 |
Predicting the metabolic characteristics of neorudin, a novel anticoagulant fusion protein, in patients with deep vein thrombosis
|
Dong, Xiaona |
|
|
194 |
C |
p. 121-134 |
artikel |
33 |
Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study
|
Picart, Gaël |
|
|
194 |
C |
p. 1-7 |
artikel |
34 |
Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit
|
Ågren, Anna |
|
|
194 |
C |
p. 98-100 |
artikel |
35 |
Risk factors for pediatric cerebral sinovenous thrombosis: A case-control study with case validation
|
Sellers, Austin |
|
|
194 |
C |
p. 8-15 |
artikel |
36 |
The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome
|
Skeith, Leslie |
|
|
194 |
C |
p. 54-56 |
artikel |
37 |
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
|
Abou-Ismail, Mouhamed Yazan |
|
|
194 |
C |
p. 101-115 |
artikel |
38 |
The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention
|
Sia, Ching-Hui |
|
|
194 |
C |
p. 16-20 |
artikel |
39 |
The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
|
Previtali, Giulia |
|
|
194 |
C |
p. 192-194 |
artikel |
40 |
The risk of bleeding and all-cause mortality with edoxaban versus vitamin K antagonists: A meta-analysis of phase III randomized controlled trials
|
Chen, Hai-Bin |
|
|
194 |
C |
p. 82-90 |
artikel |
41 |
The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia
|
Huynh, Angela |
|
|
194 |
C |
p. 135-141 |
artikel |
42 |
Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
|
Rasmussen, Peter Vibe |
|
|
194 |
C |
p. 220-221 |
artikel |
43 |
Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting
|
Murthy, Sanjay K. |
|
|
194 |
C |
p. 26-32 |
artikel |
44 |
Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
|
Overstad, Siri |
|
|
194 |
C |
p. 116-118 |
artikel |